CD34 counts to predict the adequate collection of peripheral blood progenitor cells

Bone Marrow Transplantation

Volumn 20, Issue 7, 1997, Pages 587-591

  Armitage, S ^a,b   Hargreaves, R ^a   Samson, D ^a   Brennan, M ^a   Kanfer, E ^a   Navarrete, C ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NBS   (United Kingdom)

Author keywords

CD34+ cells; Leucapheresis; Peripheral blood progenitor cells; White cell count

Indexed keywords

ANTIINFECTIVE AGENT; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; CHEMOTHERAPY; CLINICAL TRIAL; COLONY FORMING CELL; COLONY FORMING UNIT GM; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

EID: 0030662283     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700938     Document Type: Article

References (14)

1. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cells transplantation following high-dose therapy for malignancies. Blood 1991: 77: 211-213.
2. Gratwohl A, Hermans J. Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1994; 13: 5-10.
3. To LB, Roberts M, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 227-284.
4. Gianni AM, Sienna S, Bregni M et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; ii: 580-584.
5. Sutherland HJ, Eaves PM, Lansdorp GL et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808-3814.
6. Elliott C, Samson DM, Armitage S et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996; 14: 970-973.
7. + cells by flow cytometry: applications to the harvesting and transplantation of peripheral blood stem cells. In: Wunder E, Sovalat H, Henon P et al (eds). Hematopoietic Stem Cells: The Mullhouse Manual. AlphaMed Press: Dayton, 1994, pp 31-43.
8. Testa NG, Molineux G (eds). Haemopoiesis: A Practical Approach. Oxford IRL Press at University Press: Oxford, 1993.
9. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-334.
10. Zimmerman TM, Lee WJ, Bender JG et al. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 1995; 15: 439-444.
11. Besinger WI, Longin K, Applebaum S et al. Peripheral blood stem cells collected after recombinant granulocyte colony-stimulating factor: an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
12. + cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplant 1994; 13: 479-485.
13. + cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996; 17: 509-515.
14. Haas R, Mohl R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.